Obstetrical outcomes in women with history of breast cancer: a systematic review and meta-analysis Valentina D’AmbrosioFlaminia VenaAntonella Giancotti Review 26 August 2019 Pages: 485 - 492
The microbiome and breast cancer: a review Jennifer ChenJacqueline DouglassMehran Habibi Review 27 August 2019 Pages: 493 - 496
Prognostic value of receptor status conversion following neoadjuvant chemotherapy in breast cancer patients: a systematic review and meta-analysis Chao LiHongwei FanYimin Cui Review 30 August 2019 Pages: 497 - 504
Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie database E. KaczmarekC. Saint-MartinF. Lerebours Review 05 September 2019 Pages: 505 - 512
Home-based physical activity interventions for breast cancer patients receiving primary therapy: a systematic review Steven S. CoughlinLee S. CaplanValerie Williams Review 06 September 2019 Pages: 513 - 522
Primary and secondary breast angiosarcoma: single center report and a meta-analysis Yara AbdouAhmed ElkhananyMateusz Opyrchal Review Open access 14 September 2019 Pages: 523 - 533
CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy Lutfi H. AlfarsiRokaya El AnsariAndrew R. Green Preclinical study 30 August 2019 Pages: 535 - 544
Multiplex ddPCR assay for screening copy number variations in BRCA1 gene Igor OscorbinAndrey KechinMaxim Filipenko Preclinical study 03 September 2019 Pages: 545 - 555
Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing R. ScarpittaI. ZannaM. A. Caligo Preclinical Study 11 September 2019 Pages: 557 - 564
CpG methylation signature predicts prognosis in breast cancer Tonghua DuBin LiuYuanyu Wu Preclinical study 13 September 2019 Pages: 565 - 572
Cost-utility, cost-effectiveness, and budget impact of Internet-based cognitive behavioral therapy for breast cancer survivors with treatment-induced menopausal symptoms Joost G. E. VerbeekVera AtemaValesca P. Retèl Clinical trial Open access 26 August 2019 Pages: 573 - 585
Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing W. Iris ZhiPatricia ChenTing Bao Clinical trial 27 August 2019 Pages: 587 - 595
Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab? T. G. SteenbruggenN. I. BouwerG. S. Sonke Clinical trial 06 September 2019 Pages: 597 - 605
Long-term outcomes of breast-conserving therapy for women with ductal carcinoma in situ Laura E. G. WarrenYu-Hui ChenJennifer R. Bellon Clinical trial 06 September 2019 Pages: 607 - 615
Prophylactic acupuncture treatment during chemotherapy with breast cancer: a randomized pragmatic trial with a retrospective nested qualitative study Benno BrinkhausBarbara KirschbaumClaudia M. Witt Clinical trial 13 September 2019 Pages: 617 - 628
Germline pathogenic variants in BRCA1, BRCA2, PALB2 and RAD51C in breast cancer women from Argentina Roxana CerretiniGraciela MercadoMohammad R. Akbari Epidemiology 24 August 2019 Pages: 629 - 636
Effectiveness of radiotherapy after breast-conserving surgery in older patients with T1-2N0 breast cancer Anna Z. de BoerEsther BastiaannetGerrit Jan Liefers Epidemiology Open access 26 August 2019 Pages: 637 - 645
A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database study Makoto KuboMasaaki KawaiHiromitsu Jinno Epidemiology Open access 26 August 2019 Pages: 647 - 656
Inherited variants in XRCC2 and the risk of breast cancer Wojciech KluźniakDominika Wokołorczykthe Polish Hereditary Breast Cancer Consortium Epidemiology Open access 28 August 2019 Pages: 657 - 663
Validation of the online prediction model CancerMath in the Dutch breast cancer population Liza A. HovelingMarissa C. van MaarenSabine Siesling Epidemiology 30 August 2019 Pages: 665 - 681
Analysis of incidence, mortality trends, and geographic distribution of breast cancer patients in Canada François LagacéFeras M. GhazawiIvan V. Litvinov Epidemiology 04 September 2019 Pages: 683 - 691
Optimal treatment of breast cancer in women older than 75 years: a Korea Breast Cancer Registry analysis Ye Won JeonSun Hyong YouYong Seok Kim Epidemiology Open access 06 September 2019 Pages: 693 - 701
The impact of health symptoms on health-related quality of life in early-stage breast cancer survivors K. M. de LigtM. HeinsS. Siesling Epidemiology Open access 11 September 2019 Pages: 703 - 711
Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism Sora YasriViroj Wiwanitkit Letter to the Editor 26 August 2019 Pages: 713 - 713